UNSPSC 51286505: Novobiocin calcium

This classification denotes an antibiotic 2C31H35N2O11.Ca, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier RHW5BU180N, chemically known as benzamide, n-(7-((3-o-(aminocarbonyl)-6-deoxy-5-c-methyl-4-o-methyl-.alpha.-l-lyxo-hexopyranosyl)oxy)-4-hydroxy-8-methyl-2-oxo-2h-1-benzopyran-3-yl)-4-hydroxy-3-(3-methyl-2-butenyl)-, calcium salt (2:1), but more generally known as novobiocin calcium, which bears US NIH Compound Identifier 20297. Most nations schedule novobiocin calcium under HS 29419000 and SITC 54139.

UNSPSC 51286505 Novobiocin calcium is a Commodity code that represents pharmaceutical products, though state and local procurement activity under this code shows limited recent direct alignment. The recent opportunities tagged to this code center on broader pharmaceutical procurement — pharmaceutical warehouse supply contracts and medical countermeasures such as naloxone and drug deactivation systems — rather than novobiocin calcium specifically. Issuing bodies soliciting pharmaceutical products at the state and local level include state health departments and county government agencies managing public health initiatives and emergency preparedness.

Geographic activity appears concentrated in the Midwest and Southeast, with documented recent procurement from Illinois and Florida. The Illinois Department of Public Health awarded a piggyback pharmaceutical warehouse contract through the MMCAP Infuse consortium to Chartwell Rx LLC on August 28, 2026 (Solicitation 26482DPHPREPDB53392) for doxycycline and ciprofloxacin, representing $2,999,999.11 over the contract life. Seminole County, Florida issued an IFB (IFB60459723LAS) posted June 30, 2026 with a July 26, 2023 response deadline seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually through quarterly deliveries. These opportunities reflect state and local procurement of pharmaceuticals and medical countermeasures through competitive bidding and cooperative purchasing vehicles, though neither opportunity targets novobiocin calcium directly.